Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Committee Questions HHS On Spending Of Comparative Effectiveness Research Funds

This article was originally published in The Pink Sheet Daily

Executive Summary

The Energy and Commerce Committee's investigation is an example of the close scrutiny of CER activities expected of the Republican-controlled House.

You may also be interested in...



Could PhRMA Be Headed To The Energy And Commerce Committee Hot Seat For Reform Law Compromises?

Committee Chairman Upton seeks details on closed door meetings between White House and outside parties in run-up to the passage of the health care reform bill, and letter to Deputy Chief of Staff DeParle suggests drug industry deals are among targets.

Could PhRMA Be Headed To The Energy And Commerce Committee Hot Seat For Reform Law Compromises?

Committee Chairman Upton seeks details on closed door meetings between White House and outside parties in run-up to the passage of the health care reform bill, and letter to Deputy Chief of Staff DeParle suggests drug industry deals are among targets.

House Bill Aims To Dismantle PCORI, HIT Program

Repeal of provisions for the Patient-Centered Outcomes Research Institute and the Office of the National Coordinator for Health Information Technology is proposed by Republican House Policy Committee Chairman Thaddeus McCotter.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071900

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel